135 related articles for article (PubMed ID: 12699657)
21. Blood compatibility of SPUU-PEO-heparin graft copolymers.
Park KD; Kim WG; Jacobs H; Okano T; Kim SW
J Biomed Mater Res; 1992 Jun; 26(6):739-56. PubMed ID: 1527098
[TBL] [Abstract][Full Text] [Related]
22. Surface modification of polymeric biomaterials with poly(ethylene oxide), albumin, and heparin for reduced thrombogenicity.
Amiji M; Park K
J Biomater Sci Polym Ed; 1993; 4(3):217-34. PubMed ID: 8476792
[TBL] [Abstract][Full Text] [Related]
23. Platelet adhesion onto segmented polyurethane film surfaces modified by addition and crosslinking of PEO-containing block copolymers.
Lee JH; Ju YM; Kim DM
Biomaterials; 2000 Apr; 21(7):683-91. PubMed ID: 10711965
[TBL] [Abstract][Full Text] [Related]
24. In vitro blood compatibility of functional group-grafted and heparin-immobilized polyurethanes prepared by plasma glow discharge.
Kang IK; Kwon OH; Kim MK; Lee YM; Sung YK
Biomaterials; 1997 Aug; 18(16):1099-107. PubMed ID: 9247347
[TBL] [Abstract][Full Text] [Related]
25. Antithrombogenicity of hydrophilic polyurethane-hydrophobic polystyrene IPNs. II. In vitro and ex vivo studies.
Shin YC; Han DK; Kim YH; Kim SC
J Biomater Sci Polym Ed; 1994; 6(3):281-95. PubMed ID: 7986781
[TBL] [Abstract][Full Text] [Related]
26. In vivo canine studies of a Sinkhole valve and vascular graft coated with biocompatible PU-PEO-SO3.
Han DK; Lee KB; Park KD; Kim CS; Jeong SY; Kim YH; Kim HM; Min BG
ASAIO J; 1993; 39(3):M537-41. PubMed ID: 8268593
[TBL] [Abstract][Full Text] [Related]
27. Albumin immobilized polyurethane and its blood compatibility.
Ryu G; Han D; Kim Y; Min B
ASAIO J; 1992; 38(3):M644-8. PubMed ID: 1457940
[TBL] [Abstract][Full Text] [Related]
28. Chitosan based surfactant polymers designed to improve blood compatibility on biomaterials.
Sagnella S; Mai-Ngam K
Colloids Surf B Biointerfaces; 2005 May; 42(2):147-55. PubMed ID: 15833667
[TBL] [Abstract][Full Text] [Related]
29. Platelet adhesion onto segmented polyurethane surfaces modified by PEO- and sulfonated PEO-containing block copolymer additives.
Lee JH; Ju YM; Lee WK; Park KD; Kim YH
J Biomed Mater Res; 1998 May; 40(2):314-23. PubMed ID: 9549627
[TBL] [Abstract][Full Text] [Related]
30. Interaction of blood components with heparin-immobilized polyurethanes prepared by plasma glow discharge.
Kang IK; Seo EJ; Huh MW; Kim KH
J Biomater Sci Polym Ed; 2001; 12(10):1091-108. PubMed ID: 11853380
[TBL] [Abstract][Full Text] [Related]
31. Surface characteristics and blood compatibility of polyurethanes grafted by perfluoroalkyl chains.
Han DK; Jeong SY; Kim YH; Min BG
J Biomater Sci Polym Ed; 1992; 3(3):229-41. PubMed ID: 1610733
[TBL] [Abstract][Full Text] [Related]
32. Copolymers of 2-methacryloyloxyethyl phosphorylcholine (MPC) as biomaterials.
Nakabayashi N; Iwasaki Y
Biomed Mater Eng; 2004; 14(4):345-54. PubMed ID: 15472384
[TBL] [Abstract][Full Text] [Related]
33. Plasma protein adsorption and platelet adhesion onto comb-like PEO gradient surfaces.
Lee JH; Jeong BJ; Lee HB
J Biomed Mater Res; 1997 Jan; 34(1):105-14. PubMed ID: 8978659
[TBL] [Abstract][Full Text] [Related]
34. Nonfouling biomaterials based on polyethylene oxide-containing amphiphilic triblock copolymers as surface modifying additives: protein adsorption on PEO-copolymer/polyurethane blends.
Tan J; McClung WG; Brash JL
J Biomed Mater Res A; 2008 Jun; 85(4):873-80. PubMed ID: 17896776
[TBL] [Abstract][Full Text] [Related]
35. Platelet adhesion and activation on polyethylene glycol modified polyurethane surfaces. Measurement of cytoplasmic calcium.
Park KD; Suzuki K; Lee WK; Lee JE; Kim YH; Sakurai Y; Okano T
ASAIO J; 1996; 42(5):M876-81. PubMed ID: 8945010
[TBL] [Abstract][Full Text] [Related]
36. In vitro blood compatibility of heparin-immobilized polyurethane containing ester groups in the side chain.
Wan M; Baek DK; Cho JH; Kang IK; Kim KH
J Mater Sci Mater Med; 2004 Oct; 15(10):1079-87. PubMed ID: 15516868
[TBL] [Abstract][Full Text] [Related]
37. Physicochemical properties and platelet interactions of segmented polyurethanes containing sulfonate groups in the hard segment.
Skarja GA; Brash JL
J Biomed Mater Res; 1997 Mar; 34(4):439-55. PubMed ID: 9054528
[TBL] [Abstract][Full Text] [Related]
38. Surface modification of polymeric biomaterials: utilization of cyclodextrins for blood compatibility improvement.
Zhao X; Courtney JM
J Biomed Mater Res A; 2007 Mar; 80(3):539-53. PubMed ID: 17019727
[TBL] [Abstract][Full Text] [Related]
39. Hemocompatibility and cytocompatibility of styrenesulfonate-grafted PDMS-polyurethane-HEMA hydrogel.
Lin CH; Jao WC; Yeh YH; Lin WC; Yang MC
Colloids Surf B Biointerfaces; 2009 Apr; 70(1):132-41. PubMed ID: 19157804
[TBL] [Abstract][Full Text] [Related]
40. Novel anti-calcification treatment of biological tissues by grafting of sulphonated poly(ethylene oxide).
Park KD; Lee WK; Yun JY; Han DK; Kim SH; Kim YH; Kim HM; Kim KT
Biomaterials; 1997 Jan; 18(1):47-51. PubMed ID: 9003896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
